Esperion Therapeutics, Inc. (ESPR)

2d ago, source: Yahoo Finance

and MUNICH, Germany, March 22, 2024 (GLOBE NEWSWIRE) -- Daiichi Sankyo Europe GmbH (hereafter, ‘Daiichi Sankyo’) and Esperion Therapeutics, Inc. jointly announced today, that the Committ In ...

Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket

on MSN ago, source:

Shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) shares rose sharply during today’s pre-market trading after the company ...

Should You Sell Esperion Therapeutics (ESPR)?

2mon ago, source: InvestingChannel on MSN

Tourlite Capital Management featured stocks such as Esperion Therapeutics, Inc. (NASDAQ:ESPR) in the fourth quarter 2023 ...

Esperion Therapeutics Inc. (ESPR) Stock: Navigating the Market Volatility

4d ago, source: newsheater

Warren Eric, the Chief Commercial Officer of Esperion Therapeutics Inc., sale 243 shares at $1.41 during a trade that took place back on Aug 18 ’23, which means that Warren Eric is holding 69,060 ...

Esperion stock jumps as non-statin therapy shows clinical benefits across diverse patient groups

on MSN ago, source:

Read about the promising clinical benefits of Esperion Therapeutics' NEXLETOL tablets in diverse populations, including women ...

Esperion Therapeutics, Masimo And Other Big Stocks Moving Higher In Monday's Pre-Market Session

25d ago, source: Business Insider

Shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR) rose sharply in today’s pre-market trading. The U.S. FDA approved broad new labels for Esperion's NEXLETOL® and NEXLIZET® to prevent heart ...

Esperion Therapeutics, Inc. Rings the Nasdaq Stock Market Opening Bell

17d ago, source: Nasdaq

Market open and close ceremonies take place daily at the Nasdaq MarketSite Studio in Times Square and around the globe. Esperion (Nasdaq: ESPR), a pharmaceutical company who recently announced the ...

Esperion Therapeutics Inc 0ET

1mon ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Esperion Therapeutics Inc ESPR

7d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Esperion Therapeutics Inc.

25d ago, source: U.S. News & World Report

Are Financial Advisors Worth It? Beyond stock picking, today's advisors help clients plan for a wide range of financial and life goals.

Esperion Therapeutics Inc.

2mon ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...